The move to hire CordenPharma comes as the U.S. drugmaker prepares to launch the type 2 diabetes medicine for weight loss in the United States amid exploding demand for obesity drugs.
Tag Archive for: diabetes drug
Amphastar Pharmaceuticals will buy Baqsimi from Eli Lilly and Co. in a deal worth up to $1.08 billion as it aims to boost its portfolio of low blood sugar drugs, the two companies said on Monday.
The FDA will still allow continued distribution of sitagliptin containing NTTP with an acceptable intake limit of 37 ng per day and up to 246.7 ng per day.
